Drugs affecting the gastrointestinal system

EPA is an &omega-3 fatty acid abundantly available in marine organisms. (&plusmn)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

A metabolite of the CYP2C19 substrate mephenytoin that has been used for developing UPLC- MS/MS assays for evaluating CYP probe drugs and their relevant metabolites in human urine or plasma samples.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)8-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 8(S)-HEPE and 8(R)-HEPE.

Racemic version of a product of epoxide hydrolase metabolism of leukotoxin, the 9(10) epoxide of linoleic acid generated by neutrophils during the oxidative burst.

Racemic version of a product of epoxide hydrolase metabolism of leukotoxin, the 9(10) epoxide of linoleic acid generated by neutrophils during the oxidative burst.

Racemic version of a product of epoxide hydrolase metabolism of leukotoxin, the 9(10) epoxide of linoleic acid generated by neutrophils during the oxidative burst.

Racemic version of a product of epoxide hydrolase metabolism of leukotoxin, the 9(10) epoxide of linoleic acid generated by neutrophils during the oxidative burst.

The Bio Basic (+) Abscisic Acid (Dormin, ABA) with a composition of

The Bio Basic (+) Abscisic Acid (Dormin, ABA) with a composition of